Cargando…

Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis

Clinical management of gynecological cancer begins by optimal debulking with first-line platinum-based chemotherapy. However, in ~80% patients, ovarian cancer will recur and is lethal. Prognostic gene signature panel identifying platinum-resistance enables better patient stratification for precision...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunderson, Camille C, Radhakrishnan, Rangasudhagar, Gomathinayagam, Rohini, Husain, Sanam, Aravindan, Sheeja, Moore, Kathleen M, Dhanasekaran, Danny N, Jayaraman, Muralidharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966103/ https://www.ncbi.nlm.nih.gov/pubmed/35370397 http://dx.doi.org/10.1177/11772719221088404

Ejemplares similares

Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells
por: Ha, Ji Hee, et al.
Publicado: (2020)

Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
por: Jayaraman, Muralidharan, et al.
Publicado: (2017)

Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration
por: Gomathinayagam, Rohini, et al.
Publicado: (2014)

Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
por: Ha, Ji Hee, et al.
Publicado: (2016)

Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth
por: Ha, Ji Hee, et al.
Publicado: (2015)

Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus
por: Ha, Ji Hee, et al.
Publicado: (2016)

Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
por: Gomathinayagam, Rohini, et al.
Publicado: (2020)

Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer
por: Ha, Ji-Hee, et al.
Publicado: (2021)

Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019)

GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
por: Ha, Ji Hee, et al.
Publicado: (2021)

Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
por: Ramraj, Satish Kumar, et al.
Publicado: (2016)

A risk model of gene signatures for predicting platinum response and survival in ovarian cancer
por: Chen, Siyu, et al.
Publicado: (2022)

Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
por: Murakami, Ryusuke, et al.
Publicado: (2021)

Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells
por: Ha, Ji Hee, et al.
Publicado: (2021)

High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene Addiction
por: Aravindan, Natarajan, et al.
Publicado: (2016)

BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
por: Salwa, Amreen, et al.
Publicado: (2021)

Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer
por: Aravindan, Sheeja, et al.
Publicado: (2015)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

Maternal Risk Factors and Periodontal Disease: A Cross-sectional Study among Postpartum Mothers in Tamil Nadu
por: Govindasamy, Rohini, et al.
Publicado: (2017)

Novel Synthetic Monoketone Transmute Radiation-Triggered NFκB-Dependent TNFα Cross-Signaling Feedback Maintained NFκB and Favors Neuroblastoma Regression
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Molecular basis of ‘hypoxic’ breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
por: Sassu, Carolina Maria, et al.
Publicado: (2021)

Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023)

Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer
por: Aravindan, Sheeja, et al.
Publicado: (2015)

Cancer stem cells in neuroblastoma therapy resistance
por: Aravindan, Natarajan, et al.
Publicado: (2019)

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
por: Aravindan, Natarajan, et al.
Publicado: (2019)

Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy
por: Ferraresi, Alessandra, et al.
Publicado: (2021)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Irreversible EGFR Inhibitor EKB-569 Targets Low-LET γ-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma
por: Aravindan, Natarajan, et al.
Publicado: (2011)

Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells
por: Khan, Faizan H, et al.
Publicado: (2015)

Seven Genes Based Novel Signature Predicts Clinical Outcome and Platinum Sensitivity of High Grade IIIc Serous Ovarian Carcinoma
por: Liu, Gang, et al.
Publicado: (2018)

Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response
por: Mairinger, Fabian, et al.
Publicado: (2019)

Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer
por: Guo, Kaidi, et al.
Publicado: (2021)

Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
por: Khan, Faizan H., et al.
Publicado: (2015)

De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019)

Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells
por: Aravindan, Sheeja, et al.
Publicado: (2016)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts
por: Merrill, Daniel, et al.
Publicado: (2016)

Overcoming the challenges of drug development in platinum-resistant ovarian cancer
por: Eskander, Ramez N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_um294j2i6ltuvnuuls5rduod01